Here, we review the literature concerning the involvement of the 9p21.3 locus containing the CDKN2A/B genes as a prognostic marker of good or bad response in the two ALL subtypes (BCP-ALL and T-ALL). Here, CDKN2A is linked to acute lymphoblastic leukemia.